Related Experiment Video
Updated: Jan 28, 2026

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
Published on: September 19, 2025
Utilizing Extracellular Vesicles for Delivering Therapies in Neurodegenerative Disorders
Ashish Dilip Sutar1, Anuja Shashikant Kamble1, Nitin Chitranshi2
1Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER-Raebareli), Bijnor-Sisendi Road, Sarojini Nagar, Near CRPF Base Camp, Lucknow, UP, 226002, India.
None:
Neurodegenerative diseases (NDs) are characterized by slow progression and late detection, seriously compromising the efficiency of treatments. The presence of the blood-brain barrier (BBB) significantly impairs conventional therapies. More recently, extracellular vesicles (EVs) have emerged as promising drug delivery systems for brain-targeted therapies due to their ability to cross the BBB and their combination of low immunogenicity, high biocompatibility, and delivery efficiency. EVs play a vital role in intercellular communication, transporting nucleic acids, lipids, and proteins between cells, which are crucial for modulating cellular functions, immune responses, and neuroprotection. They have also demonstrated considerable therapeutic potential by mitigating neuroinflammation, reducing neuronal damage, and alleviating cognitive deficits in preclinical models of NDs. This review discusses various applications of EVs in the treatment of NDs, challenges they present as a delivery vehicle, and future research directions and regulatory considerations in advancing EV-based therapies for neurodegenerative disorders.
Related Concept Videos
Gene Therapy
Intrinsically Disordered Proteins
The Extracellular Matrix
Other Disorders of Digestive System
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...

